Global Longlife Hospital and R (GLHRL.BO)
INR 30.95
(-0.13%)
INR 30.95
(-0.13%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -50.72 Million | -404.15 Million | 94.24 Million | 68.76 Million | 38.98 Million | 54 Million |
| Net Income | -21.88 Million | 18.27 Million | 35.73 Million | 20.46 Million | -8.62 Million | 13.64 Million |
| Depreciation & Amortization | 12.5 Million | 11.66 Million | 11.43 Million | 13.04 Million | 15.33 Million | 15.53 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 296.2 Million | -409.01 Million | -8.58 Million | 32.05 Million | -21.91 Million | -28.04 Million |
| Other non-cash items | -337.54 Million | -25.07 Million | 55.65 Million | 3.18 Million | 54.19 Million | 52.87 Million |
| Investing Cash Flow | -8.17 Million | -19 Million | 132 Thousand | 175.05 Thousand | -380 Thousand | -3.29 Million |
| Investments in PPE | -10.48 Million | -20.04 Million | -4.75 Million | -423.02 Thousand | -1.06 Million | -3.98 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 2.31 Million | 1.03 Million | 4.88 Million | 598.08 Thousand | 682 Thousand | 695 Thousand |
| Financing Cash Flow | 26.73 Million | 456.99 Million | -96.59 Million | -72.22 Million | -30.52 Million | -47.65 Million |
| Debt repayment | -2.32 Million | -8.21 Million | -96.85 Million | -49.44 Million | -8.34 Million | -34.37 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 29.06 Million | 448.78 Million | 260 Thousand | -22.78 Million | -22.17 Million | -13.27 Million |
| Accounts receivables | 77.5 Million | -7.89 Million | -10.66 Million | -15.71 Million | 24.23 Million | -37.32 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | 3.78 Million | 673 Thousand | -706 Thousand | 13.82 Million | -1.76 Million | -8.92 Million |
| Other working capital | 214.9 Million | -401.79 Million | 2.78 Million | 33.94 Million | -44.39 Million | 18.2 Million |
| Cash at beginning of period | 36.01 Million | 2.18 Million | 4.39 Million | 12.87 Million | 4.79 Million | 1.74 Million |
| Cash at end of period | 3.85 Million | 36.01 Million | 2.18 Million | 4.39 Million | 12.87 Million | 4.79 Million |
| Capital Expenditure | -10.48 Million | -20.04 Million | -4.75 Million | -423.02 Thousand | -1.06 Million | -3.98 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -32.16 Million | 33.83 Million | -2.21 Million | -8.47 Million | 8.07 Million | 3.05 Million |
| Free Cash Flow | -61.21 Million | -424.19 Million | 89.49 Million | 68.34 Million | 37.91 Million | 50.01 Million |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -16.08 Million | -21.88 Million | -16.08 Million | 5.14 Million | 5.14 Million | 18.27 Million |
| Depreciation & Amortization | 3.17 Million | 12.5 Million | 3.17 Million | 3.07 Million | 3.07 Million | 11.66 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 163.47 Million | 296.2 Million | 163.47 Million | -15.37 Million | -15.37 Million | -409.01 Million |
| Other non-cash items | -169.28 Million | -337.54 Million | -169.28 Million | 510 Thousand | 510 Thousand | -25.07 Million |
| Investing Cash Flow | -289 Thousand | -8.17 Million | -289 Thousand | -3.79 Million | -3.79 Million | -19 Million |
| Investments in PPE | -1.33 Million | -10.48 Million | -1.33 Million | -3.9 Million | -3.9 Million | -20.04 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 1.05 Million | 2.31 Million | 1.05 Million | 107 Thousand | 107 Thousand | 1.03 Million |
| Financing Cash Flow | 5.34 Million | 26.73 Million | 5.34 Million | 8.02 Million | 8.02 Million | 456.99 Million |
| Debt repayment | - | -2.32 Million | - | - | - | -8.21 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 5.34 Million | 29.06 Million | 5.34 Million | 8.02 Million | 8.02 Million | 448.78 Million |
| Accounts receivables | 53.25 Million | 77.5 Million | 53.25 Million | -14.49 Million | -14.49 Million | -7.89 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | 4.28 Million | 3.78 Million | 4.28 Million | -2.39 Million | -2.39 Million | 673 Thousand |
| Other working capital | 105.93 Million | 214.9 Million | 105.93 Million | 1.51 Million | 1.51 Million | -401.79 Million |
| Cash at beginning of period | - | 36.01 Million | - | - | - | 2.18 Million |
| Cash at end of period | -13.66 Million | 3.85 Million | -13.66 Million | -2.41 Million | -2.41 Million | 36.01 Million |
| Capital Expenditure | -1.33 Million | -10.48 Million | -1.33 Million | -3.9 Million | -3.9 Million | -20.04 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -13.66 Million | -32.16 Million | -13.66 Million | -2.41 Million | -2.41 Million | 33.83 Million |
| Free Cash Flow | -20.05 Million | -61.21 Million | -20.05 Million | -10.54 Million | -10.54 Million | -424.19 Million |
TSLX
4350
SVNTF
GLYC
TMIP
BITE